Annual Current Liabilities
$280.44 M
+$19.23 M+7.36%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual total current liabilities is $280.44 million, with the most recent change of +$19.23 million (+7.36%) on December 31, 2023.
- During the last 3 years, RARE annual current liabilities has risen by +$90.83 million (+47.90%).
- RARE annual current liabilities is now at all-time high.
Performance
RARE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$285.01 M
+$12.14 M+4.45%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly total current liabilities is $285.01 million, with the most recent change of +$12.14 million (+4.45%) on September 30, 2024.
- Over the past year, RARE quarterly current liabilities has increased by +$31.03 million (+12.22%).
- RARE quarterly current liabilities is now at all-time high.
Performance
RARE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RARE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.4% | +12.2% |
| 3 y3 years | +47.9% | +109.7% |
| 5 y5 years | +275.3% | +215.6% |
RARE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.6% | at high | +70.4% |
| 5 y | 5-year | at high | +171.5% | at high | +175.9% |
| alltime | all time | at high | >+9999.0% | at high | +8840.0% |
Ultragenyx Pharmaceutical Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $285.01 M(+4.4%) |
| Jun 2024 | - | $272.87 M(+11.1%) |
| Mar 2024 | - | $245.57 M(-12.4%) |
| Dec 2023 | $280.44 M(+7.4%) | $280.44 M(+10.4%) |
| Sep 2023 | - | $253.98 M(+3.9%) |
| Jun 2023 | - | $244.38 M(+12.0%) |
| Mar 2023 | - | $218.18 M(-16.5%) |
| Dec 2022 | $261.21 M(+44.0%) | $261.21 M(+14.9%) |
| Sep 2022 | - | $227.36 M(+3.0%) |
| Jun 2022 | - | $220.64 M(+31.9%) |
| Mar 2022 | - | $167.23 M(-7.8%) |
| Dec 2021 | $181.37 M(-4.3%) | $181.37 M(+33.4%) |
| Sep 2021 | - | $135.93 M(+7.0%) |
| Jun 2021 | - | $127.07 M(+0.0%) |
| Mar 2021 | - | $127.04 M(-33.0%) |
| Dec 2020 | $189.61 M(+83.6%) | $189.61 M(-5.8%) |
| Sep 2020 | - | $201.19 M(-8.4%) |
| Jun 2020 | - | $219.73 M(+11.6%) |
| Mar 2020 | - | $196.86 M(+90.6%) |
| Dec 2019 | $103.30 M(+38.2%) | $103.30 M(+14.4%) |
| Sep 2019 | - | $90.31 M(+20.4%) |
| Jun 2019 | - | $75.01 M(+12.2%) |
| Mar 2019 | - | $66.88 M(-10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $74.72 M(+5.2%) | $74.72 M(+12.1%) |
| Sep 2018 | - | $66.68 M(+1.0%) |
| Jun 2018 | - | $66.05 M(+14.7%) |
| Mar 2018 | - | $57.58 M(-18.9%) |
| Dec 2017 | $71.01 M(+17.8%) | $71.01 M(+10.5%) |
| Sep 2017 | - | $64.26 M(+2.5%) |
| Jun 2017 | - | $62.67 M(+21.1%) |
| Mar 2017 | - | $51.76 M(-14.1%) |
| Dec 2016 | $60.26 M(+115.8%) | $60.26 M(+19.5%) |
| Sep 2016 | - | $50.43 M(+57.7%) |
| Jun 2016 | - | $31.98 M(+7.0%) |
| Mar 2016 | - | $29.88 M(+7.0%) |
| Dec 2015 | $27.92 M(+123.0%) | $27.92 M(+12.9%) |
| Sep 2015 | - | $24.73 M(+7.3%) |
| Jun 2015 | - | $23.04 M(+61.8%) |
| Mar 2015 | - | $14.24 M(+13.8%) |
| Dec 2014 | $12.52 M(+111.4%) | $12.52 M(+13.1%) |
| Sep 2014 | - | $11.07 M(+23.8%) |
| Jun 2014 | - | $8.94 M(+31.3%) |
| Mar 2014 | - | $6.81 M(+15.0%) |
| Dec 2013 | $5.92 M(+85.7%) | $5.92 M(+5.6%) |
| Sep 2013 | - | $5.61 M(+75.9%) |
| Dec 2012 | $3.19 M(+219.1%) | $3.19 M |
| Dec 2011 | $999.00 K | - |
FAQ
- What is Ultragenyx Pharmaceutical annual total current liabilities?
- What is the all time high annual current liabilities for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual current liabilities year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly current liabilities year-on-year change?
What is Ultragenyx Pharmaceutical annual total current liabilities?
The current annual current liabilities of RARE is $280.44 M
What is the all time high annual current liabilities for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual total current liabilities is $280.44 M
What is Ultragenyx Pharmaceutical annual current liabilities year-on-year change?
Over the past year, RARE annual total current liabilities has changed by +$19.23 M (+7.36%)
What is Ultragenyx Pharmaceutical quarterly total current liabilities?
The current quarterly current liabilities of RARE is $285.01 M
What is the all time high quarterly current liabilities for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly total current liabilities is $285.01 M
What is Ultragenyx Pharmaceutical quarterly current liabilities year-on-year change?
Over the past year, RARE quarterly total current liabilities has changed by +$31.03 M (+12.22%)